DOCS shares are down approximately 23% in premarket trading on May 14, 2026, following a post-earnings selloff that began after the close on May 13. Primary catalyst: Doximity issued fiscal year 2027 annual revenue guidance of $664M–$676M, falling well short of the Wall Street consensus near $697.4 million.

Analysts expect Q1 fiscal 2026 adjusted EPS of $0.29, aligning with company guidance of $0.24-$0.30. Consensus revenue forecast is $1.36 billion, down about 4.5% from $1.424 billion in Q1 last year, matching guided 4%-6% decline.

Analysts expect Q1 2026 revenue of approximately $205 million, more than tripling from $62.5 million in Q1 2025. Consensus EPS estimate is -$0.06, an improvement from -$0.11 per share a year ago.

Analysts expect Q1 2026 revenue of approximately $39.4 million, aligning with company guidance of $38-40 million and implying over 800% year-over-year growth. Consensus EPS estimate is a loss of -$0.03 to -$0.06 per share, reflecting heavy investments in growth amid rapid expansion.

Analysts expect Q1 2026 revenue of approximately $944 million, up about 34% from $701 million in Q1 2025. Consensus EPS estimate is -$0.13, an improvement from prior quarters amid ongoing investments in banking services.

Analysts expect Q1 2026 revenue of approximately $930 million, aligning closely with company's guidance of $925–$950 million. Consensus EPS estimate stands at $0.17, with focus on path to profitability after Q4 2025 net loss of $0.55 per share.

Analysts expect Q1 2026 revenue of $316 million, aligning with company's guidance of $315-317 million and implying 38% year-over-year growth. Consensus EPS (earnings per share) estimate stands at $0.06, reflecting continued profitability improvements on a non-GAAP basis.

Analysts expect Q1 2026 revenue of approximately $227 million, aligning closely with company's guidance midpoint of $227 million. Consensus non-GAAP EPS estimate stands at $2.20, within Nova's guided range of $2.13 to $2.25.

Analysts expect Q1 2026 EPS of 0.91 CNY (~$0.13 USD), down 23% year-over-year from 1.19 CNY in Q1 2025. Consensus revenue forecast stands at 18.55 billion CNY (~$2.57 billion USD), reflecting a projected 20% decline from Q1 2025's 23.3 billion CNY.

Analysts expect Q1 2026 EPS of $6.92 and revenue of $1.55 billion, reflecting continued momentum from 2025's record performance. Credicorp follows a calendar fiscal year, with Q1 spanning January to March 2026.

Analysts expect Honda Motor (HMC) to report Q4 revenue around $33 billion for the fiscal year ended March 31, 2026 (FYE March 31, 2026). Consensus EPS forecast stands at approximately -$5.74 per ADR share, reflecting anticipated heavy losses from EV strategy reassessment.

Analysts expect Q1 2026 revenue of $1.01 billion, up 12.6% from $897.1 million in Q1 2025. Consensus EPS estimate is -$0.11, an improvement from -$0.24 reported last year.

Resideo Technologies (REZI) shares plunged 15.91% to close at $30.85, following a previous close of $36.68. The primary catalyst was disappointing Q2 guidance, with revenue projected at $1.916-$1.94 billion (below consensus $1.978 billion) and adjusted EPS at $0.71-$0.75 (below $0.84).

Shares of CAI are declining approximately 14.00% on Wednesday, May 13, 2026, falling from a Tuesday, May 12 close of $18.87 to approximately $16.23 — extending a severe post-earnings selloff wave that has erased more than 30% of CAI's value year-to-date and reflects a persistent valuation compression driven by a cascade of institutional analyst price target reductions that began following the company's Q1 2026 earnings release.

GILT shares plunged 21.22% to close at $15.78 from the previous close of $20.00 on May 12, 2026. Primary catalyst: Q1 2026 earnings beat on EPS ($0.18 vs.

National Vision Holdings ( EYE ) shares plunged 22.13% to close at $16.31 from the previous close of $20.94. The sell-off followed Q1 2026 earnings release showing an EPS beat of $0.45 vs.

Shares of VACH are declining approximately 16.00% on Wednesday, May 13, 2026, falling from a Tuesday, May 12 close of $12.25 to approximately $10.29 — a continuation of extreme price volatility that triggered a trading halt for volatility on May 12 and reflects the structural mechanics of a near-empty SPAC (Special Purpose Acquisition Company) with only 82,685 public shares outstanding following a 99.67% shareholder redemption rate

CEG shares are declining approximately 7% in Wednesday's trading session, extending a post-earnings selloff that began after the company's Q1 2026 results were released on May 11. While Q1 2026 revenue and EPS both beat consensus estimates, the company's 2026 full-year EPS guidance midpoint of $11.50 came in below Wall Street's consensus expectation, triggering persistent selling pressure.

AFRM stock rose approximately +17% over the past 30 days, driven primarily by strong Q3 fiscal 2026 earnings that beat expectations on revenue and EPS. Over the past quarter, the stock gained around +31%, reflecting robust gross merchandise volume (GMV) growth and improved profitability amid resilient consumer spending.

APP shares are declining approximately 7.70% in Wednesday's trading session, with the stock falling from a prior close of $517.23 to approximately $477.3. The drop represents a sharp reversal and post-earnings fade, as markets reassess the sustainability of AppLovin's growth trajectory following last week's Q1 2026 results.